Shanghai Hansoh Biomedical Co., Ltd
4 clinical trials · Sponsor
◉ Watch Shanghai Hansoh Biomedical Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of HS-20093 Combinations in Patients With Extensive Stage Small Cell Lung Cancer (NCT07063407) | Shanghai Hansoh Biomedical Co., Ltd | 2025-07-31 |
| A Study of HS-20089 in Patients With Advanced Solid Tumors (NCT05263479) | Shanghai Hansoh Biomedical Co., Ltd | 2022-01-05 |
| ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors (NCT05276609) | Shanghai Hansoh Biomedical Co., Ltd | 2021-11-28 |
| Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults (NCT04940845) | Shanghai Hansoh Biomedical Co., Ltd | 2021-07-26 |
Track Shanghai Hansoh Biomedical Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.